MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

488255

Report Date :

25.01.2018

 

IDENTIFICATION DETAILS

 

Name :

ORTHO CLINICAL DIAGNOSTICS INDIA PRIVATE LIMITED

 

 

Registered Office :

Unit No. 403, 4th Floor, Leela Business Park Andheri Kurla Road, Andheri (East), Mumbai – 400059, Maharashtra

Tel. No.:

91-22-67879300

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

12.03.2015

 

 

Com. Reg. No.:

11-262650

 

 

Capital Investment / Paid-up Capital :

INR 663.081 Million

 

 

CIN No.:

[Company Identification No.]

U51397MH2015FTC262650

 

 

IEC No.:

Not Divulged

 

 

GSTIN/UIN:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AACCO1231C

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

  • Manufacture, Import, Export, International Trade, Wholesale Trade in Vitro Diagnostics Medical Device.

 

  • The Company is in to virtos diagnostics business wherein it provides total solutions for screening, diagnosing, monitoring and confirming diseases at an early stage.

 

[Registered Activity]

 

 

No. of Employees :

Information denied by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

B

 

Credit Rating

Explanation

Rating Comments

B

Medium Risk

Business dealings permissible on a regular monitoring basis

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2015. It is a manufacturer, importer, exporter, trader and wholesaler of vitro diagnostics medical device.

 

As per the financial of 2017, the company has achieved a massive growth in its revenue as compared to the previous year and has reported a low profitability margin.

 

The moderate financial position of the company is marked by negative reserve base.

 

Business is active. Payments are reported to be slow but correct.

 

In view of aforesaid, the company can be considered for business dealings with some caution.

 

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 25.01.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DENIED

                                                    

Management Non-Cooperative (91-22-67879300)

 

LOCATIONS

 

Registered Office :

Unit No. 403, 4th Floor, Leela Business Park Andheri Kurla Road, Andheri (East), Mumbai – 400059, Maharashtra, India 

Tel. No.:

91-22-67879300

Fax No.:

91-22-67879333

E-Mail :

kajal.mehta@orthoclnicaldiagnostics.com

Website:

www.orthoclinicaldiagnostics.com

 

 

DIRECTORS

 

AS ON 31.03.2017

 

Name :

Anand Pande

Designation :

Managing Director

Address :

1603, F Wing, Ashoka Gardens Tokersey Jivraj Marg, Sweree, Mumbai – 400015, Maharashtra, India 

Date of Birth/Age :

22.07.1968

Qualification:

MBA

Date of Appointment :

05.11.2015

DIN No.:

07326192

PAN No.:

AGUPP7121M

 

 

Name :

Thomas Mark Callihan

Designation :

Director

Address :

2128 Sherbrooke Drive Bethlehem 18015 United States

Date of Birth/Age :

04.04.1965

Date of Appointment :

12.03.2015

DIN No.:

07040980

 

 

Name :

Alexander Antonio Socarras

Designation :

Director

Address :

Calle Poniente 88, Urbanizacion Monte Alina Ponzuelo de Alarcon Madrid 28223 ES

Date of Birth/Age :

07.04.1970

Date of Appointment :

12.03.2015

DIN No.:

07040994

 

 

Name :

Mr. Nikhil Ghanashyam Datye

Designation :

Director

Address :

C-418, Raj Legacy, LBS Road Vikhroli (West), Mumbai -400083, Maharashtra, India 

Date of Birth/Age :

20.12.1978

Qualification:

CA

Date of Appointment :

05.11.2015

DIN No.:

07326195

PAN No.:

AFJPD6503P

 

 

Name :

Mr. Ravi Anand Sinha

Designation :

Director

Address :

DA9, 2nd Floor, Sector 1, Near CA Island, Saltlake City, Kolkata -700064, West Bengal, India

Date of Appointment :

24.11.2017

DIN No.:

07993796

 

 

KEY EXECUTIVES

 

Name :

Mr. Kajal Jayant Mehta

Designation :

Company Secretary

Address :

B/304, Jayshree CHS, Padma Nagar, Chikuwadi, Boriwali West, Mumbai -400092, Maharashtra, India 

Date of Birth/Age :

09.03.1987

Date of Appointment :

20.05.2016

PAN No.:

ATYPM4574C

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.03.2017

 

Names of Shareholders

No. of Shares

% of Holding

Ortho Clinical Diagnostics Netherlands BV

66241825

99.90

OCD Investment Holdings BV

66308

0.10

Total

66308133

100.00

 

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 31.07.2017

 

Category

Percentage

Promoters- Others

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

  • Manufacture, Import, Export, International Trade, Wholesale Trade in Vitro Diagnostics Medical Device.

 

  • The Company is in to virtos diagnostics business wherein it provides total solutions for screening, diagnosing, monitoring and confirming diseases at an early stage.

 

[Registered Activity]

 

 

Products / Services :

Name and Description of main products / services

NIC Code of the Product/service

Business of Manufacture, Import, Export, International Trade, Wholesale Trade in Vitro Diagnostics Medical Device.

46596

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Information denied by the management

 

 

Bankers :

Banker Name :

IDFC Bank Limited

Branch :

KRM Tower, 7th Floor, No. 1,Harrington Road, Chetpet, Chennai - 600031, Tamilnadu, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

 

Auditors :

 

Name :

Price Waterhouse and Company

Chartered Accountants

Address :

Nesco It Building 8Th Floor, Nesco It Park, Nesco Complex, Gate No. 3, Western Express Highway, Goregaon East, Mumbai, Maharashtra, India

PAN N Income-tax PAN of auditor or auditor's firm :

AAHFP0187A

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Holding Company:

  • Ortho-Clinical Diagnostics Netherlands BV, Netherlands

 

 

Other Related Parties with

whom the Company has

transactions:

  • Ortho Clinical Diagnostics, Inc
  • OCD Investment Holdings B.V.
  • Ortho Clinical Diagnostics France SAS
  • Ortho Clinical Diagnostics - SA

 


 

CAPITAL STRUCTURE

 

AS ON 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

80000000

Equity Shares

INR 10/- each

INR 800.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

66308133

Equity Shares

INR 10/- each

INR 663.081 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are INR Million]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2017

31.03.2016

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

663.081

663.081

(b) Reserves and Surplus

 

(2.550)

(11.196)

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

660.531

651.885

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

1995.383

1995.383

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long-term liabilities

 

0.000

0.000

(d) long-term provisions

 

35.428

1.207

Total Non-current Liabilities (3)

 

2030.811

1996.590

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

 

0.000

0.000

(b) Trade payables

 

1335.510

818.259

(c) Other current liabilities

 

177.842

675.625

(d) Short-term provisions

 

5.485

12.049

Total Current Liabilities (4)

 

1518.837

1505.933

 

 

 

 

TOTAL

 

4210.179

4154.408

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

1525.311

1388.678

(ii) Intangible Assets

 

471.611

603.635

(iii) Tangible assets capital work-in-progress

 

110.274

97.942

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

27.903

2.930

(d) Long-term loans and advances

 

69.256

18.730

(e) Other Non-current assets

 

3.060

4.590

Total Non-Current Assets

 

2207.415

2116.505

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

613.541

472.102

(c) Trade receivables

 

564.926

443.949

(d) Cash and bank balances

 

778.326

926.069

(e) Short-term loans and advances

 

43.109

93.509

(f) Other current assets

 

2.862

102.274

Total Current Assets

 

2002.764

2037.903

 

 

 

 

TOTAL

 

4210.179

4154.408

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2017

31.03.2016

 

SALES

 

 

 

 

Income

 

3308.545

1220.520

 

Other Income

 

25.086

0.084

 

TOTAL

 

3333.631

1220.604

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Purchases of Stock-in-Trade

 

1900.956

1008.902

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(141.438)

(472.103)

 

Employee benefit expense

 

317.284

127.900

 

Other expenses

 

589.969

296.333

 

TOTAL

 

2666.771

961.032

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

666.860

259.572

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

181.826

81.674

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

485.034

177.898

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

 

472.889

192.022

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

12.145

(14.124)

 

 

 

 

 

Less

TAX

 

3.498

(2.930)

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

 

8.647

(11.194)

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

0.13

(0.17)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

 

31.03.2017

31.03.2016

Current Maturities of Long term debt

 

NA

NA

 

 

 

 

Cash generated from operations

 

NA

NA

 

 

 

 

Net cash flows from (used in) operations

 

12.145

(14.124)

 

 

 

 

Net cash flows from (used in) operating activities

 

12.145

(14.124)

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

Average Collection Days

(Sundry Debtors / Income * 365 Days)

 

62.32

132.76

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

 

5.86

2.75

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

 

256.43

296.03

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

 

1.09

0.55

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

 

0.32

0.12

 

LEVERAGE RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

 

0.83

0.84

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

 

3.02

3.06

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

 

2.30

2.31

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

 

3.19

3.21

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

 

3.67

3.18

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

 

31.03.2017

31.03.2016

Net Profit Margin

((PAT / Sales) * 100)

%

 

0.26

(0.92)

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

 

0.21

(0.27)

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

 

1.31

(1.72)

 

SOLVENCY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

Current Ratio

(Current Assets / Current Liabilities)

 

1.32

1.35

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

 

0.91

1.04

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

 

0.16

0.16

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

 

3.01

3.01

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

 

1.32

1.35

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

Share Capital

663.081

663.081

Reserves & Surplus

(11.196)

(2.550)

Money received against share warrants

0.000

0.000

Share Application money pending allotment

0.000

0.000

Net worth

651.885

660.531

 

 

 

Long-term borrowings

1995.383

1995.383

Short term borrowings

0.000

0.000

Current maturities of long-term debts

0.000

0.000

Total borrowings

1995.383

1995.383

Debt/Equity ratio

3.061

3.021

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

Sales

1220.520

3308.545

 

 

171.077

 

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

Sales

1220.520

3308.545

Profit/ (Loss)

(11.194)

8.647

 

(0.92 %)

0.26 %

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last two years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last two years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

GENERAL INFORMATION:

 

Subject is a private limited company incorporated in India on 12th March, 2015 under the Companies Act, 2013. The Company is in to virtos diagnostics business wherein it provides total solutions for screening, diagnosing, monitoring and confirming diseases at an early stage. The Company is wholly owned subsidiary of Ortho-Clinical Diagnostics Netherlands BV.

 

INFORMATION ON THE STATE OF COMPANY’S AFFAIR:

 

During the year, the Company achieved a turnover of INR 3333.631 Million. The management is optimistic about the Company’s future and is implementing various plans and policies for its growth and expansion. During the year, the company has made a profit of INR. 8.647 Million.

 

UNSECURED LOANS:

 

(INR In Million)

Particulars

As on

31.03.2017

As on

31.03.2016

LONG TERM BORROWING

 

 

Fully convertible debentures others

1995.383

1995.383

Total

1995.383

1995.383

 

 

 

 

INDEX OF CHARGE:

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

AMOUNT

ADDRESS

1

G73668220

100146920

IDFC BANK LIMITED

26/12/2017

66000000.0

KRM TOWER, 7TH FLOOR, NO. 1,HARRINGTON ROAD, CHETPET,CHENNAITA600031IN

2

G58743865

100129833

IDFC BANK LIMITED

05/10/2017

100000000.0

KRM TOWER, 7TH FLOOR, NO. 1,HARRINGTON ROAD, CHETPET,CHENNAITA600031IN

3

C73073769

10607520

CITYBANK N.A.

05/10/2015

100000.0

4TH FLOOR D.N. ROADFORT BRNACH, FORTMUMBAIMH400001IN

 

 

FIXED ASSETS:

 

Tangible assets

 

  • Plant and equipment
  • Furniture and fixtures
  • Office equipment
  • Computer equipments
  • Leasehold improvements

 

Intangible assets

 

  • Goodwill
  • Commercial contractual rights

 

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 63.64

UK Pound

1

INR 89.32

Euro

1

INR 78.45

 

 

INFORMATION DETAILS

 

Information Gathered by :

KAM

 

 

Analysis Done by :

NYT

 

 

Report Prepared by :

KVT

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.